Status:
COMPLETED
A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 1
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
This crossover, glucose-clamp study will investigate the impact of different basal insulin infusion rates on glucose control employing insulin pumps with different insulin delivery regimen. Patients w...
Eligibility Criteria
Inclusion
- Male patients 18-65 years of age
- Type I diabetes mellitus
- Currently on continuous subcutaneous insulin infusion therapy
Exclusion
- Proliferative retinopathy or maculopathy requiring actue treatment within last 6 months
- Use of systemic corticoids in last 3 months
- Treatment with medication known to interfere with glucose metabolism
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00772356
Start Date
January 1 2008
End Date
May 1 2008
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuss, Germany, 41460